Aaron K. Sato

4.3k total citations
41 papers, 2.5k citations indexed

About

Aaron K. Sato is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Aaron K. Sato has authored 41 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Radiology, Nuclear Medicine and Imaging, 22 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Aaron K. Sato's work include Monoclonal and Polyclonal Antibodies Research (23 papers), T-cell and B-cell Immunology (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Aaron K. Sato is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (23 papers), T-cell and B-cell Immunology (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Aaron K. Sato collaborates with scholars based in United States, Australia and Italy. Aaron K. Sato's co-authors include Lawrence J. Stern, Rachel B. Kent, Malini Viswanathan, Clive R. Wood, Robert C. Ladner, Mark de Souza, Laura Santambrogio, Alexander Steiner, Trevor J. Hallam and Gang Yin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Aaron K. Sato

40 papers receiving 2.4k citations

Peers

Countries citing papers authored by Aaron K. Sato

Since Specialization

Citations

This map shows the geographic impact of Aaron K. Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron K. Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron K. Sato more than expected).

Fields of papers citing papers by Aaron K. Sato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron K. Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron K. Sato. The network helps show where Aaron K. Sato may publish in the future.

Co-authorship network of co-authors of Aaron K. Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron K. Sato. A scholar is included among the top collaborators of Aaron K. Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron K. Sato. Aaron K. Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A multi-faceted discovery strategy identifies functional antibodies binding to cysteine-rich domain 1 of hDKK1 for cancer immunotherapy via Wnt non-canonical pathway 2025 ·Oncogene ·(unknown), Sean M. Peterson, (unknown), Ana González Hernández, Tom Z. Yuan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ryan Stafford, Fumiko Axelrod, Aaron K. Sato	0
2	A VHH single-domain platform enabling discovery and development of monospecific antibodies and modular neutralizing bispecifics against SARS-CoV-2 variants 2024 ·PubMed ·(unknown), Tom Z. Yuan, (unknown), Lin Ding, (unknown), (unknown), (unknown), (unknown), Edgar Davidson, Benjamin J. Doranz, Kartik Chandran, Emily Happy Miller, Jessica A. Plante, Scott C. Weaver, (unknown), Shweta Kailasan, (unknown), (unknown), Yasmina Abdiche, Aaron K. Sato	1
3	Discovery of a potent, selective, and tumor-suppressing antibody antagonist of adenosine A2A receptor 2024 ·PLoS ONE ·(unknown), Pankaj Garg, (unknown), Tom Z. Yuan, Ana González Hernández, (unknown), Sean M. Peterson, (unknown), (unknown), (unknown), (unknown), (unknown), Joyce Lai, Fumiko Axelrod, Colby Souders, (unknown), Aaron K. Sato	1
4	Optimization of a Glucagon-Like Peptide 1 Receptor Antagonist Antibody for Treatment of Hyperinsulinism 2023 ·Diabetes ·Sean M. Peterson, Christine A. Juliana, (unknown), (unknown), (unknown), (unknown), Ana González Hernández, (unknown), (unknown), (unknown), (unknown), Ryan Stafford, Fumiko Axelrod, Tom Z. Yuan, Diva D. De León, Aaron K. Sato	6
5	Discovery and design of G protein-coupled receptor targeting antibodies 2023 ·Expert Opinion on Drug Discovery ·Sean M. Peterson, Catherine J. Hutchings, (unknown), (unknown), (unknown), Fumiko Axelrod, Aaron K. Sato	5
6	Eliminating Bottlenecks in mAb Drug Discovery 2020 ·Genetic Engineering & Biotechnology News ·Aaron K. Sato	1
7	Post-Exposure Protection in Mice against Sudan Virus by a Two Antibody Cocktail 2018 ·Viruses ·Jeffrey W. Froude, Andrew S. Herbert, Thibaut Pelat, Sebastian Miethe, Samantha E. Zak, Jennifer M. Brannan, Russell R. Bakken, Alexander Steiner, Gang Yin, Trevor J. Hallam, Aaron K. Sato, Michael Hust, Philippe Thullier, John M. Dye	16
8	Targeted Drug Delivery with an Integrin-Binding Knottin–Fc–MMAF Conjugate Produced by Cell-Free Protein Synthesis 2016 ·Molecular Cancer Therapeutics ·Nicolas Currier, Shelley E. Ackerman, James R. Kintzing, (unknown), (unknown), Alexander Steiner, Aaron K. Sato, Jennifer R. Cochran	30
9	Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency 2015 ·Clinical Cancer Research ·Wan-Ching Yen, Marcus Fischer, Fumiko Axelrod, Christopher J. Bond, Jennifer Cain, Belinda Cancilla, (unknown), René Meisner, Aaron K. Sato, Jalpa Shah, Tracy Tang, Breanna Wallace, Min Wang, Chun Zhang, Ann M. Kapoun, John Lewicki, Austin Gurney, Timothy Hoey	195
10	A simplified and robust protocol for immunoglobulin expression in Escherichia coli cell‐free protein synthesis systems 2015 ·Biotechnology Progress ·Cai Qi, Jeffrey Hanson, Alexander Steiner, Cuong Tran, (unknown), (unknown), James Zawada, Aaron K. Sato, Trevor J. Hallam, Gang Yin	76
11	Methods to Make Homogenous Antibody Drug Conjugates 2014 ·Pharmaceutical Research ·Toni Kline, Alexander Steiner, Kalyani Penta, Aaron K. Sato, Trevor J. Hallam, Gang Yin	54
12	DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency 2009 ·Cell stem cell ·Timothy Hoey, Wan-Ching Yen, Fumiko Axelrod, (unknown), (unknown), Scott J. Dylla, (unknown), Sasha Lazetic, Inkyung Park, Aaron K. Sato, Sanjeev Satyal, Xinhao Wang, Michael F. Clarke, John Lewicki, Austin Gurney	318
13	Discovery of Fully Human Anti-MET Monoclonal Antibodies with Antitumor Activity against Colon Cancer Tumor Models In Vivo 2009 ·Neoplasia ·Edward H. van der Horst, Lawrence Chinn, Min Wang, (unknown), Hoang Tran, (unknown), Andrew Lam, May Ji, Timothy Hoey, Aaron K. Sato	48
14	Therapeutic peptides: technological advances driving peptides into development 2006 ·Current Opinion in Biotechnology ·Aaron K. Sato, Malini Viswanathan, Rachel B. Kent, Clive R. Wood	290
15	Discovery of human antibodies against the C5aR target using phage display technology 2005 ·Journal of Molecular Recognition ·Lili Huang, Aaron K. Sato, Meena Sachdeva, T J Fleming, (unknown), Daniel T. Dransfield	14
16	Nitriles form mixed-coligand complexes with 99mTc-HYNIC-Peptide 2002 ·Nuclear Medicine and Biology ·Guozheng Liu, Charles R. Wescott, Aaron K. Sato, Yi Wang, Ning Liu, Yumin Zhang, Mary Rusckowski, Donald J. Hnatowich	12
17	Development of Mammalian Serum Albumin Affinity Purification Media by Peptide Phage Display 2002 ·Biotechnology Progress ·Aaron K. Sato, Daniel J. Sexton, (unknown), Edward H. Cohen, (unknown), Greg Conley, (unknown), (unknown), Mary Devlin, Daniel B. DeOliveira, (unknown), Rachel B. Kent, Charles R. Wescott, (unknown), Arthur C. Ley, Robert C. Ladner	73
18	Determinants of the Peptide-induced Conformational Change in the Human Class II Major Histocompatibility Complex Protein HLA-DR1 2000 ·Journal of Biological Chemistry ·Aaron K. Sato, (unknown), Mia Rushe, Aleksey Lomakin, (unknown), Scheherazade Sadegh‐Nasseri, George B. Benedek, Lawrence J. Stern	72
19	Empty and Peptide-Loaded Class II Major Histocompatibility Complex Proteins Produced by Expression inEscherichia coliand Foldingin Vitro 1999 ·Protein Expression and Purification ·(unknown), Aaron K. Sato, Lihui Xu, Lawrence J. Stern	91
20	Steady-state and time-resolved phosphorescence of wild-type and modified bacteriophage λcI repressors 1994 ·Journal of Fluorescence ·Aaron K. Sato, (unknown), Donald F. Senear, J. B. Alexander Ross, Kenneth W. Rousslang	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact